PLAQUENIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Plaquenil, and what generic alternatives are available?
Plaquenil is a drug marketed by Concordia and is included in one NDA.
The generic ingredient in PLAQUENIL is hydroxychloroquine sulfate. There are fifteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the hydroxychloroquine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Plaquenil
A generic version of PLAQUENIL was approved as hydroxychloroquine sulfate by TEVA PHARMS on September 30th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PLAQUENIL?
- What are the global sales for PLAQUENIL?
- What is Average Wholesale Price for PLAQUENIL?
Summary for PLAQUENIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 75 |
| Clinical Trials: | 106 |
| Patent Applications: | 4,322 |
| Drug Prices: | Drug price information for PLAQUENIL |
| What excipients (inactive ingredients) are in PLAQUENIL? | PLAQUENIL excipients list |
| DailyMed Link: | PLAQUENIL at DailyMed |
Recent Clinical Trials for PLAQUENIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Incannex Healthcare Ltd | Phase 2 |
| Yoo-min Kim | Phase 3 |
| Ministry of Health & Welfare, Korea | Phase 3 |
Pharmacology for PLAQUENIL
| Drug Class | Antimalarial Antirheumatic Agent |
US Patents and Regulatory Information for PLAQUENIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concordia | PLAQUENIL | hydroxychloroquine sulfate | TABLET;ORAL | 009768-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
